Yüklüyor......
Denosumab causing severe, refractory hypocalcaemia in a patient with chronic kidney disease
Denosumab is a fully human monoclonal antibody that is being increasingly used for the treatment of osteoporosis and prevention of skeletal-related events (SREs) in bone metastases from primary tumours. It has improved efficacy, better tolerability and convenient administration via subcutaneous rout...
Kaydedildi:
| Yayımlandı: | BMJ Case Rep |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990053/ https://ncbi.nlm.nih.gov/pubmed/29848528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-224068 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|